SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013673
Filing Date
2022-08-15
Accepted
2022-08-15 17:56:53
Documents
82
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrxp-20220630x10q.htm   iXBRL 10-Q 1392991
2 EX-10.1 nrxp-20220630xex10d1.htm EX-10.1 127535
3 EX-31.1 nrxp-20220630xex31d1.htm EX-31.1 15356
4 EX-31.2 nrxp-20220630xex31d2.htm EX-31.2 15420
5 EX-32.1 nrxp-20220630xex32d1.htm EX-32.1 7087
6 EX-32.2 nrxp-20220630xex32d2.htm EX-32.2 6409
7 GRAPHIC nrxp-20220630xex10d1001.jpg GRAPHIC 6410
8 GRAPHIC nrxp-20220630xex10d1002.jpg GRAPHIC 10696
  Complete submission text file 0001558370-22-013673.txt   7063407

Data Files

Seq Description Document Type Size
9 EX-101.SCH nrxp-20220630.xsd EX-101.SCH 67078
10 EX-101.CAL nrxp-20220630_cal.xml EX-101.CAL 34699
11 EX-101.DEF nrxp-20220630_def.xml EX-101.DEF 262462
12 EX-101.LAB nrxp-20220630_lab.xml EX-101.LAB 408255
13 EX-101.PRE nrxp-20220630_pre.xml EX-101.PRE 408788
76 EXTRACTED XBRL INSTANCE DOCUMENT nrxp-20220630x10q_htm.xml XML 1222590
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38302 | Film No.: 221167280
SIC: 2834 Pharmaceutical Preparations